Thus, the poor patient prognosis found in P-cadherin overexpressing breast cancer cases [10] may be related, at least partially, to the fact that this cadherin enables cells to respond to integrin signaling, promoting an oncogenic response. Here, CDH17 is linked to breast carcinoma.